Easywell Biomedicals, Inc. (1799.TWO)
TWD 62.7
(2.96%)
TWD 62.7
(2.96%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 271.62 Million | 178.89 Million | 197.27 Million | 267.65 Million | 359.96 Million |
| Cost of Revenue | 100.91 Million | 102.58 Million | 146.84 Million | 183.69 Million | 324.5 Million |
| Gross Profit | 170.71 Million | 76.31 Million | 50.43 Million | 83.96 Million | 35.46 Million |
| Operating Expenses | 333.45 Million | 237.57 Million | 262.29 Million | 242.82 Million | 251.43 Million |
| Selling, General and Administrative Expenses | 61.95 Million | 28.16 Million | 24.14 Million | 21.21 Million | 26.1 Million |
| Research and Development Expenses | 271.49 Million | 209.41 Million | 238.14 Million | 221.61 Million | 236.34 Million |
| Other Expenses | - | 8.04 Million | 57.1 Million | -8.28 Million | -11.01 Million |
| Cost and Expenses | 434.36 Million | 340.15 Million | 409.13 Million | 426.51 Million | 575.93 Million |
| Operating Income | -162.73 Million | -151.02 Million | -153.57 Million | -166.74 Million | -215.97 Million |
| Interest Expense | 19.25 Million | 17.24 Million | 16.08 Million | 16.07 Million | 18.3 Million |
| Income Tax Expense | 256 Thousand | 119 Thousand | 849 Thousand | 2.02 Million | 656 Thousand |
| Earnings before Tax | -169.9 Million | -168.27 Million | -169.66 Million | -182.81 Million | -268.2 Million |
| Net Income | -144.81 Million | -161 Million | -150.39 Million | -173.41 Million | -271.79 Million |
| Earnings Per Share Basic | -1.25 | -1.39 | -1.44 | -1.84 | -3.16 |
| Earnings Per Share Diluted | -1.25 | -1.39 | -1.44 | -1.84 | -3.55 |
| Weighted Average Shares Outstanding | 115.68 Million | 115.62 Million | 104.12 Million | 94.29 Million | 86.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 115.68 Million | 115.62 Million | 104.12 Million | 94.29 Million | 76.59 Million |
| Gross Margin | 0.63 | 0.43 | 0.26 | 0.31 | 0.10 |
| EBIT Margin | -0.31 | -0.47 | -0.42 | -0.32 | -0.41 |
| Profit Margin | -0.53 | -0.90 | -0.76 | -0.65 | -0.76 |
| EBITDA | -85.5 Million | -84.48 Million | -82.69 Million | -85.81 Million | -161.91 Million |
| Earnings Before Tax Margin | -0.60 | -0.84 | -0.78 | -0.62 | -0.60 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 122.88 Million | 73.41 Million | 97.03 Million | 271.62 Million | 68.15 Million | 69.47 Million |
| Cost of Revenue | 46.89 Million | 29.74 Million | 33.56 Million | 100.91 Million | 21.14 Million | 26.84 Million |
| Gross Profit | 75.99 Million | 43.67 Million | 63.47 Million | 170.71 Million | 47 Million | 42.62 Million |
| Operating Expenses | 92.69 Million | 96.51 Million | 112.3 Million | 333.45 Million | 85.87 Million | 69.63 Million |
| Selling, General and Administrative Expenses | 21.25 Million | 23.83 Million | 38.39 Million | - | 10.77 Million | 7.48 Million |
| Research and Development Expenses | 71.44 Million | 72.67 Million | 73.91 Million | - | 75.1 Million | 62.14 Million |
| Other Expenses | 573 Thousand | 1.47 Million | -1.46 Million | 8.67 Million | 7 Million | 4.39 Million |
| Cost and Expenses | 139.59 Million | 126.25 Million | 145.86 Million | 434.36 Million | 107.02 Million | 96.47 Million |
| Operating Income | -14.54 Million | -50.46 Million | -49.08 Million | -150.65 Million | -31.33 Million | -21.91 Million |
| Interest Expense | 4.95 Million | 5.02 Million | 5.3 Million | 19.25 Million | 4.91 Million | 4.72 Million |
| Income Tax Expense | 90 Thousand | 66 Thousand | 110 Thousand | 256 Thousand | 69 Thousand | 77 Thousand |
| Earnings before Tax | -20.68 Million | -55.65 Million | -54.38 Million | -169.9 Million | -36.24 Million | -26.63 Million |
| Net Income | -21.88 Million | -48.16 Million | -44.27 Million | -144.81 Million | -27.12 Million | -24.71 Million |
| Earnings Per Share Basic | -0.18 | -0.41 | -0.38 | - | -0.24 | -0.22 |
| Earnings Per Share Diluted | -0.18 | -0.41 | -0.38 | - | -0.24 | -0.22 |
| Weighted Average Shares Outstanding | 121.6 Million | 117.48 Million | 116.58 Million | 115.68 Million | 114.24 Million | 113.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 121.6 Million | 117.48 Million | 116.58 Million | 115.68 Million | 114.24 Million | 113.56 Million |
| Gross Margin | 0.62 | 0.59 | 0.65 | 0.63 | 0.69 | 0.61 |
| EBIT Margin | 0.04 | -0.45 | -0.33 | - | -0.22 | -0.08 |
| Profit Margin | -0.18 | -0.66 | -0.46 | -0.53 | -0.40 | -0.36 |
| EBITDA | 5.11 Million | -33.18 Million | -32.25 Million | - | -14.77 Million | -5.85 Million |
| Earnings Before Tax Margin | -0.12 | -0.69 | -0.51 | -0.55 | -0.46 | -0.32 |
TITR
BZAMF
0676
NEX
3865
CYB